Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ellagic Acid and Annona Muricata for High Risk HPV
NCT02263378Completed
- Sponsor
- University of Messina
- Start
- Sep 2014
- Primary completion
- Mar 2016
01
Overview
Randomised trial (2 arms), sponsored by University of Messina. Primary endpoint: Variation of onco suppressor protein expression from basal values at 6 months. Started Sep 2014; status: completed.
Beyond the preview
Go deeper on NCT02263378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02263378.